13F-HR filed by Avidity Partners Management LP
Avidity Partners Management LP filed this 13F-HR for the quarter ended 2024-06-30, filed 2024-08-14, with 85 holding rows worth $2,353,381,213.
- Accession
- 0001791827-24-000007
- Filer
- CIK 1791827
- Filed
- 2024-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2024
A holdings report, 85 entries on the cover page, a total value of $2,353,381,213 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,353,381,213 with VALUE read as dollars as filed, 13F file number 028-20028. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Intuitive Surgical,Inc. | 46120E602 | COM | 245,000 | $108,988,250 | dollars as filed | |
| Boston Scientific Corporation | 101137107 | COM | 1,170,100 | $90,109,401 | dollars as filed | |
| NATERA INC COM | 632307104 | Stock | 766,500 | $83,004,285 | dollars as filed | |
| ARVINAS INC | 04335A105 | COM | 2,987,845 | $79,536,434 | dollars as filed | |
| ACADIA HEALTHCARE COMPANY INC COM | 00404A109 | Stock | 1,120,000 | $75,644,800 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 2,917,231 | $75,497,938 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 3,335,000 | $68,467,550 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 491,000 | $67,595,970 | dollars as filed | |
| AVANTOR INC COM | 05352A100 | Stock | 3,086,000 | $65,423,200 | dollars as filed | |
| Cigna Corporation | 125523100 | COM | 184,500 | $60,990,165 | dollars as filed | |
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 544,500 | $58,114,485 | dollars as filed | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 222,000 | $53,946,000 | dollars as filed | |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 48,000 | $50,449,440 | dollars as filed | |
| ILLUMINA INC | 452327109 | COM | 478,000 | $49,893,640 | dollars as filed | |
| TENET HEALTHCARE CORP COM NEW | 88033G407 | Stock | 372,000 | $49,487,160 | dollars as filed | |
| AbbVie,Inc. | 00287Y109 | COM | 277,800 | $47,648,256 | dollars as filed | |
| Thermo Fisher Scientific Inc. | 883556102 | COM | 80,000 | $44,240,000 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 1,075,000 | $42,215,250 | dollars as filed | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 383,000 | $41,279,740 | dollars as filed | |
| CG ONCOLOGY INC | 156944100 | COMMON STOCK | 1,296,225 | $40,921,823 | dollars as filed | |
| Merck & Co.,Inc. | 58933Y105 | COM | 325,000 | $40,235,000 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 960,000 | $39,456,000 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 1,117,000 | $39,217,870 | dollars as filed | |
| Danaher Corporation | 235851102 | COM | 150,000 | $37,477,500 | dollars as filed | |
| JANUX THERAPEUTICS INC | 47103J105 | COM | 840,219 | $35,196,774 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 110,000 | $35,040,500 | dollars as filed | |
| INCYTE CORP COM | 45337C102 | Stock | 529,000 | $32,067,980 | dollars as filed | |
| SURGERY PARTNERS INC | 86881A100 | COM | 1,306,477 | $31,081,088 | dollars as filed | |
| PERSPECTIVE THERAPEUTICS INC | 46489V302 | COMMON STOCK | 3,037,668 | $30,285,550 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 376,000 | $30,268,000 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 754,000 | $29,398,460 | dollars as filed | |
| DEXCOM INC COM | 252131107 | Stock | 259,000 | $29,365,420 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 755,000 | $29,301,550 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 430,000 | $28,810,000 | dollars as filed | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 400,000 | $27,396,000 | dollars as filed | |
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 1,559,826 | $27,203,365 | dollars as filed | |
| GLAUKOS CORP COM | 377322102 | Stock | 224,000 | $26,510,400 | dollars as filed | |
| NEUROGENE INC | 64135M105 | COMMON STOCK | 727,537 | $26,475,071 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 60,500 | $26,017,420 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 731,104 | $24,996,446 | dollars as filed | |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 531,000 | $24,128,640 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 908,000 | $23,971,200 | dollars as filed | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 1,100,000 | $23,683,000 | dollars as filed | |
| LANTHEUS HLDGS INC | 516544103 | COM | 290,000 | $23,284,100 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 284,000 | $21,444,840 | dollars as filed | |
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 487,000 | $19,163,450 | dollars as filed | |
| JASPER THERAPEUTICS INC | 471871202 | COM NEW | 782,000 | $17,751,400 | dollars as filed | |
| NEUMORA THERAPEUTICS INC. | 640979100 | COM | 1,800,000 | $17,694,000 | dollars as filed | |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 398,000 | $17,627,420 | dollars as filed | |
| Gilead Sciences,Inc. | 375558103 | COM | 255,000 | $17,495,550 | dollars as filed | |
| PHATHOM PHARMACEUTICALS INC | 71722W107 | COMMON STOCK | 1,620,000 | $16,686,000 | dollars as filed | |
| ASTRAZENECA PLC SPONSORED ADR | 046353108 | ADR | 205,000 | $15,987,950 | dollars as filed | |
| KEROS THERAPEUTICS INC COM | 492327101 | Stock | 343,200 | $15,684,240 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 450,000 | $15,619,500 | dollars as filed | |
| SANOFI SA SPONSORED ADR | 80105N105 | ADR | 315,000 | $15,283,800 | dollars as filed | |
| REGENXBIO INC | 75901B107 | COM | 1,300,064 | $15,210,749 | dollars as filed | |
| CONTEXT THERAPEUTICS INC | 21077P108 | COM | 7,419,355 | $14,875,807 | dollars as filed | |
| EXACT SCIENCES CORP COM | 30063P105 | Stock | 338,500 | $14,301,625 | dollars as filed | |
| PRIVIA HEALTH GROUP INC | 74276R102 | COM | 764,200 | $13,281,796 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 559,300 | $10,744,153 | dollars as filed | |
| IMMUNOME INC | 45257U108 | COM | 873,891 | $10,574,081 | dollars as filed | |
| IMMUNIC INC | 4525EP101 | COM | 8,902,972 | $9,882,299 | dollars as filed | |
| CORBUS PHARMACEUTICALS | 21833P301 | COM NEW | 215,600 | $9,755,900 | dollars as filed | |
| CYBIN INC | 23256X100 | COM | 34,884,000 | $9,453,564 | dollars as filed | |
| SYROS PHARMACEUTICALS INC | 87184Q206 | COM NEW | 1,673,538 | $8,635,456 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 1,000,706 | $8,435,952 | dollars as filed | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 200,000 | $6,778,000 | dollars as filed | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 373,000 | $5,964,270 | dollars as filed | |
| UIPATH INC | 90364P105 | CL A | 362,000 | $4,590,160 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 195,000 | $4,584,450 | dollars as filed | |
| IMMATICS N.V | N44445109 | SHS | 393,100 | $4,567,822 | dollars as filed | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 93,000 | $4,432,380 | dollars as filed | |
| ORUKA THERAPEUTICS INC COM | 00211Y506 | Stock | 1,000,000 | $3,830,000 | dollars as filed | |
| EDITAS MEDICINE INC | 28106W103 | COM | 816,000 | $3,810,720 | dollars as filed | |
| INTELLIA THERAPEUTICS INC | 45826J105 | COM | 170,000 | $3,804,600 | dollars as filed | |
| COLLEGIUM PHARMACEUTICAL INC | 19459J104 | COM | 117,000 | $3,767,400 | dollars as filed | |
| PRIME MEDICINE INC | 74168J101 | COM | 694,000 | $3,567,160 | dollars as filed | |
| AC IMMUNE SA | H00263105 | SHS | 825,000 | $3,291,750 | dollars as filed | |
| KEZAR LIFE SCIENCES INC | 49372L100 | COM | 5,026,000 | $3,015,600 | dollars as filed | |
| SCYNEXIS INC | 811292200 | COM NEW | 1,448,728 | $2,897,456 | dollars as filed | |
| KARYOPHARM THERAPEUTICS INC | 48576U106 | COM | 2,018,500 | $1,751,251 | dollars as filed | |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 350,000 | $1,746,500 | dollars as filed | |
| HYPERFINE INC | 44916K106 | Common Stock | 1,188,178 | $1,009,951 | dollars as filed | |
| CAREMAX INC | 14171W202 | COM | 21,200 | $59,148 | dollars as filed | |
| NUVATION BIO INC | 67080N119 | WARR | 12,136 | $1,942 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001791827-24-000007 | this filing | 2024-08-14 | acceptance time not in the bulk data set |